Cognigen Presents Hands-On Course Using NONMEM

• Email
• Share
  • Digg
  • Facebook
  • LinkedIn

Jill Fiedler-Kelly, vice president and chief scientific officer of Cognigen Corporation, will present a 3-day introductory workshop in population PK data analysis from Thursday May 13 through Saturday May 15, 2010. The workshop is geared to pharmaceutical and biotech industry scientists and to advanced graduate students in pharmaceutics and clinical pharmacology who have done little or no modeling previously.

This workshop, given in conjunction with the University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences, will provide a comprehensive understanding of the population PK approach to data analysis using formal lectures; review of data, code, and data analysis results; and hands-on exercises. Participants will practice coding control streams, running various models, and evaluating results at individual computer terminals.

Fiedler-Kelly is an adjunct assistant professor at UB and is in her 10th year of presenting the workshop. “Even though the essence of the material has not changed over the years,” says Fiedler-Kelly, “I get new insights each time I teach it. I use real-life examples based on my work at Cognigen, and my Cognigen experience helps me understand and explain concepts and techniques more thoroughly each year.”

Fiedler-Kelly also teaches a graduate-level course at UB on population pharmacokinetic–pharmacodynamic modeling in which students learn the skills of NONMEM analysis.

The 3-day workshop precedes Pharmacokinetic–Pharmacodynamic Modeling: Concepts and Applications, a workshop presented by William J. Jusko, PhD, distinguished professor and chair of pharmaceutical sciences in the School of Pharmacy and Pharmaceutical Sciences at the University of Buffalo and director of the Center of Excellence in Pharmacokinetics and Pharmacodynamics.

The Department of Pharmaceutical Sciences at the University at Buffalo of the State University of New York is considered one of the top departments in the world in pharmacokinetics, pharmacodynamics and biopharmaceutics.